EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RGD peptide hydrogel downregulates mechanosignal YAP to inhibit postoperative scarring

Yao Lv, Licheng Liang, Mian Qin, Ru-Ping Jiang, Fei-Fei Zong, Xia Wu, Kai-Li Wu, Liang Liang

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.04.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Yao Lv und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second People's Hospital of Yichang, China Three Gorges University, Yichang, Hubei 443003, China; Center for Disease…. Hauptthemen laut MEDLINE: Hydrogels, Oligopeptides, Cicatrix, Down-Regulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: State Key Laboratory of Ophthalmology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Glaucoma filtration failure may result from an overabundance of human Tenon's capsule fibroblasts (HTFs) forming a filtration tract scar. Conversely, the Yes-associated protein (YAP), a transcriptional activator of the Hippo signaling pathway, is a crucial matrix stiffness regulator of matrix production and fibroblast activation. With superior biocompatibility and biodegradability, RGD peptide hydrogels imitate the structure of real tissues' extracellular matrix (ECM). The purpose of this research was to determine whether down-regulating YAP expression via RGD peptide hydrogels may prevent HTFs activation and ECM protein secretion. Transforming growth factor-β2 (TGF-β2) was used to induce the activation of HTFs in a cellular model of scarring following glaucoma filtration surgery. Utilizing SD rats, a murine model of subconjunctival injury was established. The shape of collagen fibers was observed through Masson staining, and the expression of YAP and α-smooth muscle actin (α-SMA) was identified through immunohistochemistry. RGD peptide hydrogel was discovered to have anti-scarring properties in a mouse eye injury model, as well as the ability to lessen HTFs activation, YAP expression, cytosolic nucleus accumulation, and the expression of connective tissue growth factor (CTGF) and ECM proteins. The best concentration was found to be 1.0 weight percent among them. This concentration not only makes it easier to inject a drug subconjunctivally in vivo and maintain the filtration vesicle space in the conjunctiva, but it also inhibits the activation of fibroblasts into myofibroblasts and down-regulates the expression of the Hippo-YAP signaling pathway in Tenon's capsule fibroblasts. STATEMENT OF SIGNIFICANCE: 1. The homogenous reticular three-dimensional nanostructure that made up the interior structure of the 1.0 weight percent gel had good drug delivery characteristics for long-lasting controlled drug release. 2. RGD peptide hydrogel had a certain matrix hardness, which could mimic the normal connective tissue hardness under the conjunctiva. 3. RGD peptide hydrogels could prevented the development of rat conjunctival fibrosis. 4. RGD peptide hydrogel could inhibit the expression of YAP and its target gene CTGF, as well as α-SMA, ECM proteins in HTFs. 5. RGD peptide hydrogel has good biocompatibility, biodegradability, and stable mechanical properties, and can also be used as a promising carrier for the controlled release of drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsOligopeptidesCicatrixDown-RegulationAdaptor Proteins, Signal TransducingPostoperative ComplicationsAnimalsYAP-Signaling ProteinsRats, Sprague-DawleyHumansRatsFibroblastsMaleMiceTranscription FactorsCell Cycle ProteinsExtracellular Matrix

Stichwörter der Autor:innen

Extracellular matrixRGD peptide hydrogelScarringTenon's capsule fibroblastsYes-associated protein

Substanzen

HydrogelsYAP-Signaling ProteinsOligopeptidesarginyl-glycyl-aspartic acidTranscription FactorsAdaptor Proteins, Signal TransducingYap1 protein, ratCell Cycle ProteinsYAP1 protein, human

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second People's Hospital of Yichang, China Three Gorges University, Yichang, Hubei 443003, China; Center for Disease Control and Prevention, High-Tech Zone, Yichang, Hubei, China.
  • Department of Ophthalmology, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
  • Department of Ophthalmology, The Second People's Hospital of Yichang, China Three Gorges University, Yichang, Hubei 443003, China.
  • Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
  • Department of Ophthalmology, The Second People's Hospital of Yichang, China Three Gorges University, Yichang, Hubei 443003, China. Electronic address: liangliang419519@126.com.

Förderung

  • State Key Laboratory of Ophthalmology
  • National Natural Science Foundation of China

Zitieren

APA

Lv, Y., Liang, L., Qin, M., Jiang, R. P., Zong, F. F., Wu, X., Wu, K. L., & Liang, L. (2025). RGD peptide hydrogel downregulates mechanosignal YAP to inhibit postoperative scarring. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.04.059

Vancouver

Lv Y, Liang L, Qin M, Jiang RP, Zong FF, Wu X, et al. RGD peptide hydrogel downregulates mechanosignal YAP to inhibit postoperative scarring. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.04.059

BibTeX
@article{Lv2025,
  author = {Lv, Yao and Liang, Licheng and Qin, Mian and Jiang, Ru-Ping and Zong, Fei-Fei and Wu, Xia and Wu, Kai-Li and Liang, Liang},
  title = {RGD peptide hydrogel downregulates mechanosignal YAP to inhibit postoperative scarring},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.04.059}
}
Kostenlos starten →